TrialJAMA network open2024

Olaparib Addition to Maintenance Bevacizumab Therapy in Ovarian Carcinoma With BRCA-Like Genomic Aberrations.

Philip C Schouten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.